PvD1, Defensin D1

General Information


DRACP ID  DRACP02324

Peptide Name   PvD1, Defensin D1

Sequence  KTCENLADTYKGPCFTTGSCDDHCKNKEHLRSGRCRDDFRCWCTKNC

Sequence Length  47

UniProt ID  V7BTW4  F8QXP9 

PubChem CID  Not available

Origin  Phaseolus vulgaris

Type  Native peptide

Classification

  

Active ACP Induce apoptosis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma IC50=0.82±0.14 µM MTT assay 24 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  MCF-10a: 50% Cell death=7 µM

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02324

Helicity  Not available

Linear/Cyclic  Cyclic

Disulfide/Other Bond  Cys3<--->Cys47; Cys14<--->Cys35; Cys20<--->Cys41; Cys24<--->Cys43

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C222H346N72O73S8

Absent amino acids  IMQV

Common amino acids  C

Mass  626880

Pl  7.98

Basic residues  11

Acidic residues  7

Hydrophobic residues  6

Net charge  4

Boman Index  -16068

Hydrophobicity  -114.89

Aliphatic Index  18.72

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  7490

Absorbance 280nm  162.83

Polar residues  22

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 29076508

Title  Challenging metastatic breast cancer with the natural defensin PvD1

Doi 10.1039/c7nr05872a

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4120

DRACP is developed by Dr.Zheng's team.